Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer

被引：0
|
作者：
Churchill, Timothy W. [1 ]
Smith, Matthew R. [1 ]
Michaelson, M. Dror [2 ]
Lee, Richard J. [2 ]
Guseh, James Sawalla
Wasfy, Meagan M.
Meneely, Erika
Olivier, Kara
Baggish, Aaron L. [3 ]
Saylor, Philip J.
机构：
[1] Harvard Med Sch, Cardiovasc Performance Program, Div Cardiol, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Med, Dept Med, Boston, MA USA
[3] Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland
来源：
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY | 2024年 / 37卷 / 07期
基金：
美国国家卫生研究院;
关键词：
CARDIOVASCULAR-DISEASE; MORTALITY;
D O I：
10.1016/j.echo.2024.03.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：706 / 708
页数：3
相关论文
共 50 条
  • [21] Cardiovascular risk during androgen deprivation therapy for prostate cancer
    Jones, Thomas Hugh
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [22] PATHOLOGICAL-CHANGES OF ANDROGEN DEPRIVATION THERAPY FOR PROSTATE-CANCER
    MURPHY, WM
    SOLOWAY, MS
    BARROWS, GH
    LABORATORY INVESTIGATION, 1991, 64 (01) : A49 - A49
  • [23] Thresholds of Body Composition Changes Associated with Survival During Androgen Deprivation Therapy in Prostate Cancer
    Chen, Pin-Chi
    Chiang, Pai-Kai
    Lin, Jhen-Bin
    Tsai, Wei-Kung
    Lin, Wan-Chun
    Jan, Ya-Ting
    Wu, Kun-Pin
    Lee, Jie
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 70 : 99 - 108
  • [24] Osteoporosis and Other Adverse Body Composition Changes during Androgen Deprivation Therapy for Prostate Cancer
    Matthew R. Smith
    Cancer and Metastasis Reviews, 2002, 21 : 159 - 166
  • [25] Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer
    Smith, MR
    CANCER AND METASTASIS REVIEWS, 2002, 21 (02) : 159 - 166
  • [26] Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer
    Smith, MR
    UROLOGY, 2004, 63 (04) : 742 - 745
  • [27] Insulin resistance during androgen deprivation therapy in men with prostate cancer
    Basaria, Shehzad
    Taplin, Mary-Ellen
    McDonnell, Marie
    Simonson, Donald C.
    Lin, Alexander P.
    Dufour, Alyssa B.
    Habtemariam, Daniel
    Nguyen, Paul L.
    Ravi, Praful
    Kibel, Adam S.
    Sweeney, Christopher J.
    D'Amico, Anthony V.
    Roberts, Daniel A.
    Xu, Wenxin
    Wei, Xiao X.
    Sunkara, Rajitha
    Choudhury, Atish D.
    Mantia, Charlene
    Beltran, Himisha
    Pomerantz, Mark
    Berchuck, Jacob E.
    Martin, Neil E.
    Leeman, Jonathan E.
    Mouw, Kent W.
    Kilbridge, Kerry E.
    Bearup, Richelle
    Kackley, Hannah
    Kafel, Hussein
    Huang, Grace
    Reid, Kieran F.
    Storer, Thomas
    Braga-Basaria, Milena
    Travison, Thomas G.
    CANCER, 2024, 130 (21) : 3671 - 3685
  • [28] Sleep and daily functioning during androgen deprivation therapy for prostate cancer
    Hanisch, L. J.
    Gooneratne, N. S.
    Soin, K.
    Gehrman, P. R.
    Vaughn, D. J.
    Coyne, J. C.
    EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (04) : 549 - 554
  • [29] Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
    Keating, Nancy L.
    O'Malley, A. James
    Smith, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4448 - 4456
  • [30] miRNAs and androgen deprivation therapy for prostate cancer
    Konoshenko, Maria Yu
    Bryzgunova, Olga E.
    Laktionov, Pavel P.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
12345